Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation - Archive ouverte HAL Access content directly
Journal Articles The Journal of Pediatrics Year : 2021

Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation

, , , , , , , , , , , , , , , , , (1) , ,
1
Stéphane Ducassou
  • Function : Author
Helder Fernandes
Hélène Savel
  • Function : Author
Yves Bertrand
  • Function : Author
Thierry Leblanc
  • Function : Author
Wadih Abou Chahla
  • Function : Author
Marlène Pasquet
  • Function : Author
Guy Leverger
  • Function : Author
Vincent Barlogis
Caroline Thomas
Sophie Bayart
  • Function : Author
Isabelle Pellier
  • Function : Author
Corinne Armari-Alla
  • Function : Author
Corinne Guitton
  • Function : Author
Nathalie Cheikh
Djamel Kherfellah
  • Function : Author
Gilles Vassal
Salim Laghouati
  • Function : Author
Nathalie Aladjidi
  • Function : Author
Not file

Dates and versions

hal-03481515 , version 1 (15-12-2021)

Identifiers

Cite

Stéphane Ducassou, Helder Fernandes, Hélène Savel, Yves Bertrand, Thierry Leblanc, et al.. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. The Journal of Pediatrics, 2021, 231, pp.223-230. ⟨10.1016/j.jpeds.2020.12.018⟩. ⟨hal-03481515⟩

Collections

INRIA INRIA2 U1219
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More